Skip to main content
EN
Caution:
At present, there are occasional discrepancies in the display of intellectual property rights holders and their representatives. We are working on a solution.
Patent Search
Details
Details for 2019186196
Up to date per 09.06.2026
Actions
Copy link to European Patent
Download Registration Print
Details
Details for 2019186196
Title / Product Name
SUBLINGUALE FORMULIERUNG VON RILUZOL
Status
Deleted
Protection Type
European Patent
(AT-) Application Number
2019186196
EP Publication Number
3616686
E-Number
1393310
Language
EN
PCT Number
Publication Date
04.03.2020 A
19.05.2021 B1
Registration Date
19.05.2021
AT Publication Date
15.06.2021
Application Date
17.11.2015
Registration Number
-
Priorities
21.11.2014
US
201462083094 P
IPC
A61K 9/00 20060101AFI20201016BHEP
Maximum Duration of Protection
17.11.2035
Owner
Biohaven Pharmaceutical Holding Company Ltd.
234 Church Street Suite 301
New Haven, CT 06520
US
Representative
No representatives present
Inventor
CORIC, Vladimir
7 Richborough Road
Madison, CT 06443
US
BERMAN, Robert, M.
77 Livingston Street
New Haven, CT 06511
US